Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
BD Increases Domestic Production to Support U.S. Health Care Need for Syringes | ||||||||||||||||
By: PR Newswire Association LLC. - 21 Mar 2024 | Back to overview list |
|||||||||||||||
FRANKLIN LAKES, N.J., March 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the March 19, 2024 U.S. Food and Drug Administration (FDA) Safety Communication, which provided important updates on FDA's ongoing evaluation of certain plastic syringes: Eric Borin, president of BD Medication Delivery Solutions said, "BD has the capacity to support additional syringe demand and is further increasing U.S. production to help ensure continuity of patient care. Since the initial FDA safety communication in November, BD has increased domestic manufacturing of syringes in our Nebraska and Connecticut facilities to respond to customer needs. "Ensuring the safety and quality of our products is the top priority at BD. The latest FDA safety communication does not include any BD syringes. Over our more than 125-year history, we have served the health care system's need for essential high quality medical products, including manufacturing 2 billion additional syringes and needles to support the global pandemic response to COVID-19. BD remains committed to supporting the health care system and patients, and our clinical staff are prepared to support customers with any questions they may have regarding our products." For more information on BD's commitment to quality, safety and our customers, please visit: https://www.bd.com/en-us/about-bd/quality-at-bd. About BD
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-increases-domestic-production-to-support-us-health-care-need-for-syringes-302095818.html SOURCE BD (Becton, Dickinson and Company) |
||||||||||||||||
|
||||||||||||||||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |